GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Endoscopy/EUS, TIPS and Cavernous Transformation of the Portal Vein

EUS, TIPS and Cavernous Transformation of the Portal Vein

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated January 1, 2026

Quick Answer

EUS (Endoscopic Ultrasound), TIPS (Transjugular Intrahepatic Portosystemic Shunt), and Cavernous Transformation of the Portal Vein (CTPV) are interconnected concepts in the management of portal hypertension and its complications, particularly in patients with liver cirrhosis and CTPV. Here's a detailed explanation of these terms and their relationship: ### 1.


EUS (Endoscopic Ultrasound), TIPS (Transjugular Intrahepatic Portosystemic Shunt), and Cavernous Transformation of the Portal Vein (CTPV) are interconnected concepts in the management of portal hypertension and its complications, particularly in patients with liver cirrhosis and CTPV. Here's a detailed explanation of these terms and their relationship:

### 1. **Cavernous Transformation of the Portal Vein (CTPV):**

  • CTPV refers to a condition where the portal vein becomes blocked or thrombosed (due to conditions such as portal vein thrombosis), leading to the formation of a network of collateral veins around the obstructed portal vein. These collateral veins attempt to bypass the blockage to maintain blood flow to the liver.
  • This condition often arises in patients with liver cirrhosis, portal hypertension, or hypercoagulable states.
  • CTPV poses significant clinical challenges, including:
  • **Recurrent variceal hemorrhage** (bleeding from enlarged veins in the esophagus or stomach).
  • **Ascites** (accumulation of fluid in the abdominal cavity).
  • Increased risk of complications due to the altered portal venous anatomy.

### 2. **TIPS (Transjugular Intrahepatic Portosystemic Shunt):**

  • TIPS is a minimally invasive procedure used to treat complications of portal hypertension, such as variceal bleeding and refractory ascites.
  • The procedure involves creating a shunt (connection) between the portal vein and a hepatic vein within the liver using a stent. This reduces portal vein pressure by allowing blood to bypass the liver and flow directly into the systemic circulation.
  • **Challenges in CTPV:**
  • In patients with CTPV, the portal vein is thrombosed or replaced by a network of collateral veins, making it technically difficult to perform TIPS.
  • The success rate of TIPS in patients with a patent portal vein is high (over 95%), but it drops to 60-70% in patients with CTPV due to the altered anatomy and difficulty in locating the portal vein.

### 3. **EUS (Endoscopic Ultrasound):**

  • EUS is a diagnostic and therapeutic tool that uses ultrasound imaging via an endoscope inserted into the gastrointestinal tract. It provides high-resolution images of structures adjacent to the GI tract, including the portal vein.
  • **Role in TIPS for CTPV:**
  • EUS can be used to guide the localization of the portal vein in patients with CTPV. This is particularly important because traditional TIPS relies on indirect navigation and blind needle puncture, which carries a high risk of complications like intra-abdominal hemorrhage.
  • In the study mentioned, EUS was used to locate the portal vein and mark it with a metallic coil. This coil served as a direct target for TIPS puncture, significantly improving the accuracy and safety of the procedure.

### 4. **EUS-TIPS Hybrid Approach:**

  • The integration of EUS-guided portal vein localization with TIPS represents a novel and innovative approach to managing CTPV.
  • **Key Findings from the Study:**
  • The study demonstrated the technical success and safety of combining EUS with TIPS in a cohort of 10 patients with liver cirrhosis and CTPV.
  • All patients successfully underwent the procedure without EUS-related adverse events.
  • During follow-up, no patients experienced recurrent variceal hemorrhage or ascites, although 30% of patients developed overt hepatic encephalopathy (a known complication of TIPS).
  • This hybrid approach addresses the limitations of traditional TIPS in CTPV and offers a safer and more effective alternative for these high-risk patients.

### 5. **Conclusion:**

  • The combination of EUS and TIPS represents a paradigm shift in the management of CTPV, providing a more precise and safer method for treating complications of portal hypertension in patients with altered portal venous anatomy.
  • This novel approach has the potential to improve clinical outcomes and expand the applicability of TIPS in challenging cases like CTPV.

Related Q&A

EndoBarrier Improves Diabetes and Weight Loss: Ann Surg | July 2026

Introduction: Endoscopic metabolic therapies have emerged as less invasive alternatives to bariatric surgery for patients with obesity and poorly controlled type 2 diabetes mellitus (T2DM). The EndoBarrier duodenal-jejunal bypass liner (DJBL) is an endoscopically placed...

Immediate Endoscopic Necrosectomy in Necrotizing Pancreatitis: Gastroenterology | July 2026

Introduction: Endoscopic ultrasound (EUS)-guided transmural drainage is the standard minimally invasive treatment for symptomatic necrotizing pancreatitis. However, the optimal timing of direct endoscopic necrosectomy (DEN) following drainage remains uncertain. While the conventional step-up approach reserves...

Endoscopy After Bevacizumab Appears Safe: GIE | July 2026

Introduction: Bevacizumab is widely used in metastatic colorectal cancer (mCRC) because of its survival benefits but is associated with impaired wound healing, gastrointestinal perforation, and bleeding. These concerns often lead clinicians to delay endoscopic procedures...

Colorectal ESD Perforation: Endoscopy | July 2026

Introduction: Endoscopic submucosal dissection (ESD) enables en bloc resection of large colorectal neoplasms with excellent oncological outcomes. However, concerns about perforation have limited its widespread adoption. This large prospective multicenter study evaluated the incidence, risk...

Duodenal Mucosal Resurfacing REMAIN-1 Study: DDW | 2026

Introduction: Obesity has become one of the greatest global health challenges. New incretin-based therapies—including semaglutide, tirzepatide, resmetirom, and SGLT2 inhibitors such as empagliflozin—have transformed the treatment of obesity, diabetes, and MASLD. However, many patients discontinue...

EUS-FNAB for Solid Pancreatic Lesions: GIE | July 2026

Introduction: Endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) is the standard technique for diagnosing solid pancreatic lesions. Traditionally, biopsy specimens are processed for cytology, often requiring on-site cytopathology support. This multicenter prospective study evaluated whether directly placing...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer